25.

26.

27.

28.

29.

for hydromorphone, methadone, morphine sulfate and oxycodone. The
Respondent prescribed these drugs while her license was summarily suspended.
On May 11, 2017, the Board issued a subpoena to the Prescription Drug
Monitoring Program (“PDMP") for all controlled substances written by the
Respondent from April 25, 2017 to the present.

The PDMP report revealed that the Respondent wrote over 250 prescriptions for
controlled substances while her license was summarily suspended .*

On May 11, 2017, the Board issued a subpoena to the Respondent for all
“appointment logs/patient logs/sign-in sheets for patients seen by Janet L.
Wasson, M.D. at [the Respondent's practice address] for the time period of April
25, 2017 to present.”

In response to the Board's subpoena, the Respondent transmitted daily
appointment logs that revealed that she had seen over 100 patients from April
25, 2017 through May 9, 2017, during which time her license was summarily
suspended.

The Respondent's conduct, in whole or in part, constitutes violations of the
following disciplinary grounds under the Act: is guilty of unprofessional conduct
(Health Occ. § 14-404(a)(3)(ii)); is professionally, physically or mentally
incompetent (Health Occ. § 140-404(a)(4)); fails to meet appropriate standards
as determined by appropriate peer review for the delivery of quality medical and

surgical care performed in an outpatient surgical facility, office, hospital, or any

* The PDMP report includes only those prescriptions that were filled by pharmacies. The report does not
include prescriptions written by the Respondent that pharmacies chose not to fill.

10
